martedì 21 febbraio 2017

DENTAL IMPLANT WITH SLOW-RELEASE DRUG RESERVOIR REDUCES INFECTION RISK

From
Web site


Published: Thursday 19 January 2017

Scientists have developed a dental implant containing a reservoir for the slow release of drugs. Laboratory tests in which the reservoir slowly released a strong antimicrobial agent showed that the new implant can prevent and eliminate bacterial biofilms - a major cause of infection associated with dental implants.

The researchers, from various departments at KU Leuven in Belgium, describe how they designed and tested the implant in a paper published in the journal European Cells & Materials.
Lead author Dr. Kaat De Cremer, from the Centre of Microbial and Plant Genetics at KU Leuven, explains that the reservoir in the implant can be filled by removing the cover screw. 
She adds that:
"The implant is made of a porous composite material, so that the drugs gradually diffuse from the reservoir to the outside of the implant, which is in direct contact with the bone cells. As a result, the bacteria can no longer form a biofilm."

lunedì 20 febbraio 2017

NEW MEDICAL DEVICES REGULAMENTATION - PERSON RESPONSIBLE FOR REGULATORY COMPLIANCE

Luca Martinelli

Publication 25th November 2016

1.FOREWORD

It’s appropriate to underline that as of today (25.11.2016) the Official Journal has not published yet the new regulation. This fact doesn’t prevent to make some considerations about some new features in the final draft.

The new Regulation of the European Parliament of the Council on medical devices, amending Directive 2001/83/CE, Regulation (CE) nr. 178/2002 and Regulation (CE) nr. 1223/2009 will replace Directives 90/385/CEE “on the approximation of the States member relating the active implantable medical devices” and 93/42/CEE “on medical devices”, establishes the figure of the “person responsible for regulatory compliance”.

2.PERSON RESPONSIBLE FOR REGULATORY COMPLIANCE

2.1 Who is him?
The new Regulation requires that the manufacturer must ensure that the supervision and control of medical devices manufacturing, as well as the supervisory and post-market surveillance activities related to them, are carried out within the organization of the manufacturer by a person responsible for regulatory compliance in fulfillment of minimum qualification requirements.

2.2 What should he do?
The person responsible for regulatory compliance has got the task of ensuring that at least:
1-    The compliance of the devices is adequately controlled in accordance with the quality management system according to which the devices are manufactured, before a product (medical device) is relased
2-    The technical documentation and declaration of conformity are established and updated
3-    Met the post-market surveillance obligations according to the reference articles
4-    Accident reporting obligations would be satisfied
5-    In case of under investigation devices, would be issued the declaration foreseen

2.3 What qualification should have he?
The person responsible for regulatory compliance must have a deep knowledge in the field of medical devices. These knowledge can be demonstrated woth a certificate from one of the following qualifications:
1-    diploma, certificate or other evidence of obtained university studies or a recognized course as equivalent by the member state concerned in medicine, pharmacy, engineering or other rilevant fields and at least two years of professional experience in the field of regulation or quality management systems related to devices.
Alternatively:
2- five years of professional experience in the field of regulation connected to the devices, including experience in quality management systems.

3.WHO IS OBLIGED TO HAVE THIS PROFESSIONAL?

3.1 The manufacturer
The manufacturer based in the EU must ensure that the supervision and control of the production of medical devices, as well as the supervisory activities and post-marketing surveillance, are carried out within its organization by a person responsible for regulatory compliance have the minimum qualification requirements.


3.2 The agent
Similarly the appointed representative in the European Union, that is, the one who plays the role of the manufacturer’s representative who is based outside the European Union, ha salso the obligation to have a person responsible for regulatory compliance.
It must have permanently and continuously. The person in charge must possess specialized knowledge in the field of regulations applicable to medical devices in the European Union. Specialized knowledge shall be proved by one of the following qualifications: 
1- diploma, certificate or other evidence of obtained university studies or a recognized course as equivalent by the member state concerned in medicine, pharmacy, engineering or other rilevant fields and at least two years of professional experience in the field of regulation or quality management systems related to devices.
Alternatively:
2- five years of professional experience in the field of regulation connected to the devices, including experience in quality management systems.

In this case the qualification requirements of the person responsible for regulatory compliance are different only in part b).
It’s not requested experience related to the field of regulation with more experience in quality system management but experience related to the field of regulation or, alternatively, experience in quality system management related to medical devices.

4. REGISTRATION IN EUROPEAN DATABASE

On registration of devices in the European database (UDI), the manufaturers, agents and importers where applicable will also indicate the name, address, and contact details of the person responsible for the regulatory compliance.

5.DEROGATION AND AXCEPTIONS 

5.1 Custom medical devices manufacturer
The Custom medical devices manufacturer is a particular figure, which doesn’t meet the manufacturer’s standards of in series manufactured devices (eg. the dental technician).
To these the possession of specialized knowledge is demonstrated by at least two years of professional experience in the manufacture of devices. 
This rule may vary depending on the provisions relating professional qualifications in force in the European Union member countries.

5.2 Micro and small enterprises manufacturer
Micro and small enterprises within the meaning of Recommendation 2003/361/CE are not required to have a person responsible for regulatory compliance within their organization but are required to have it available in a permanent and continuous basis.

Staff headcount and thresholds in the Commission Recommendation, which define the categories of companies:
1- The category of micro, small and medium-sized enterprises which employ fewer than 250 persons and which have an annual turnover not exceeding EUR 50 million or whose annual balance sheet total not exceeding 43 million Euro;
2- Within the SME category, a small enterprise is defined as an enterprise employing less thank 50 persons and whose annual turnover or annual balance sheet total not exceeding 10 million Euro; 
3- In the SME category, a microenterprise is defined as an enterprise employing less than 10 persons and whose annual turnover or annual balance sheet total not exceeding EUR 2 million.

6. EXTENSIONS OF THE MANUFACTURER’S OBLIGATIONS

Depending on the activity, importers, distributors or other natural or legal persons assume the same obligations of the manufacturers in the event that:
1- put a device available on the market under its own name, its trade name or registered trade mark, except in cases where a distributor or importer make an agreement with a manufacturer by means of which the manufacturer is identified as such on the label and it is responsible for meeting the obligations incumbent on manufacturers;
2- from changing the destination of a device already placed on the market or put into service; 
3- modify a device already placed on the market or put into service so that its compliance with applicable requirements may be affected.  

The first subparagraph shall not apply to persons who, although not considered a manufacturer as defined in the Regulation, mountain or adapt to its destination for a specific patient an existing device on the market.

7. CONTRACTUAL RELATIONSHIP

The regulation does not indicate the type of contractual relationship between the manufacturer and the person responsible for regulatory compliance because it is not necessary that a company may have a person with the necessary qualifications.

Hence, the role can also be covered by:

1- An external consultant with which the manufacturer gives the task of periodic, continuous, permanent and systematic presence;
2- A consultant with whom the manufacturer, in the case of micro or small enterprise, make a contract where the consultanti s available permanently and continuously.

About this matter we recollect that on the role of Head of the Prevention and Protection Service in response to a ruling (response of 04/11/2014 Prot. 37/0018423/MA007.A001 ruling 24/2014) the Ministry of work clarified that:
Omissis
“La modifica introdotta dal Decreto Legge n. 69/2013, convertito in Legge n. 98/2013, pone in capo al datore di lavoro l’obbligo di organizzare il SPP (Servizio di Prevenzione e Protezione) prioritariamente all’interno. 
Appare evidente che il legislatore abbia voluto sottrarre la scelta al datore di lavoro la facoltà di optare liberamente fra servizi esterni ed interni favorendo la scelta di quest’ultimo. A norma poi del comma 4 del suddetto articolo il ricorso a persone o servizi esterni è obbligatorio in assenza di dipendenti che, all’interno dell’azienda ovvero dell’unità produttiva, siano in possesso dei requisiti di cui all’articolo 32."
Omissis
“Tale previsione è ovviamente motivata dalla necessità di assicurare una presenza costante e continuativa del servizio prevenzione all’interno dell’azienda”
Omissis
“In tale quadro, dunque, il termine interno non può intendersi equivalente alla definizione di dipendente, ma deve essere sostanzialmente riferito ad un lavoratore che assicuri una presenza adeguata per lo svolgimento della propria attività.”

7.CONCLUSIONS

- The new regulation of medical devices introduces the figure of person responsible for regulatory compliance - PRRC.
- The person responsible for regulatory compliance has got a high degree of specialization. He has experience training and working specific and cross in technical, regulatory and operational. 

- The person responsible for regulatory compliance can be a consultant or an employee.

giovedì 16 febbraio 2017

NUOVO STRUMENTO PER LABORATORIO ODONTOTECNICO - NEW LABORATORY INSTRUMENT



Quasar Dental Equipment presenta GREENBRUSH, il nuovo strumento da laboratorio per modellazione.
Quasar Dental Equipment presents GREENBRUSH, the new carver laboratory instrument.

GREENBRUSH è composto da un manico in resina atossica e acciaio INOX sul quale si possono applicare a proprio piacimento una delle sei punte più utilizzate per la modellazione di ceramica, composito ecc. insieme a un pennellino monouso.
GREENBRUSH is made with an atoxic resin handle and stanley Steel where you can put one of the six tips used for carving ceramic, composite and so on, together with a disposable brush.


                  GREENBRUSH



GREENBRUSH si aggiunge al già noto REDTIP strumento per modellazione che permette di inserire le punte su entrambi i lati.
GREENBRUSH is added to REDTIP already known instrument for carving which permits to insert the tips on both sides. 


REDTIP




mercoledì 15 febbraio 2017

GOOGLE GLASS PER DENTISTI



L'impiego in campo medico-chirurgico dei Google glass è già noto ma la prima applicazione al mondo per il settore dentistico per i Google glass è nata in Italia. I Google glass per dentisti si chiamano “Dental Class”.

Gherò, noto distributore e fabbricante OBL italiano di dispositivi medici per odontoiatria, e Sell Well, agenzia italiana di marketing che si occupa di strategie di di consulting, conception, creativity, communication e controlling, hanno sviluppato il primo software per dentisti aplicato ai Google Glass.

Grazie a questa applicazione il dentista potrà ottimizzare i tempi e migliorare le prestazioni sul paziente avendo continuamente a disposizioni le informazioni su di esso. Le nuove informazioni acquisite sul paziente possono essere digitalizzate in tempo reale.
I Dental Class si indossano durante il lavoro sul paziente.


Il minicomputer, posizionato sulla stanghetta destra dei Google Glass, si collega direttamente al software sul pc dello studio permettendo di visualizzare in tempo reale l’anamnesi del paziente, i dati contenuti nella cartella clinica come radiografie, foto ecc.
Per mezzo di semplici e brevi comandi vocali l’operatore può ad esempio dettare note da inserire nella cartella del paziente, o richiamare la documentazione clinica.


Una cosa da non sottovalutare è la possibilità di eseguire foto e filmati mentre si opera sul paziente. 

Questo aspetto è importante non solo per una questione di ottimizzazione del lavoro e di raggiungimento del successo ma anche per questioni legali. In caso di contenzioso, purtroppo ormai oggi molto frequente, sarà possibile dimostrare di aver fatto il correttamente il lavoro sul paziente.

Dental Technologies Integration's srl è l'azienda di Trento che su commessa della GERHO' Spa di Bolzano, ha realizzato l'App (DeORglass) che consente di avere il controllo, della parte clinico-dentale, tramite quelli che sono stati ribattezzati Dental Class.



Unico distributore in Italia è GHERO’.

lunedì 13 febbraio 2017

TRUMP TO PHARMA CEOS: 75% TO 80% OF FDA REGULATIONS WILL BE ELIMINATED

From

Website

Posted 32 January 2017


"In a sign of what’s to come for the US Food and Drug Administration (FDA), President Donald Trump told pharmaceutical company CEOs Tuesday that his administration will be “cutting regulations at a level no one has ever seen before.”
The comments, which came before the meeting with CEOs from industry group PhRMA, Merck, Novartis, Johnson & Johnson, Celgene and others, Trump said in terms of the drug approval process: “We’re also going to be streamlining the process, so that from your standpoint, when you have a drug you can actually get it approved, instead of waiting for many, many years."
He also called for significantly lower drug prices and again for better negotiations on drug prices between Medicare and companies.
“We’re going to get the approval process much faster,” he repeated, noting that “one thing that’s always disturbed me is that you come up with a new drug for a patient that’s terminal and FDA says you can’t have this drug used on this patient and patient will be dead… we don’t know if drug works or doesn’t work, but the patient’s not going to live for more than 4 weeks.” "

domenica 12 febbraio 2017

FDA CONFIRMS ELEVATED LEVELS OF BELLADONNA IN CERTAIN HOMEOPATHIC TEETHING PRODUCTS

From
Web site

Published: Monday 30 January 2017 
"The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label. The agency is warning consumers that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and children and urges consumers not to use these products.
In light of these findings, the FDA contacted Standard Homeopathic Company in Los Angeles, the manufacturer of Hyland's homeopathic teething products, regarding a recall of its homeopathic teething tablet products labeled as containing belladonna, in order to protect consumers from inconsistent levels of belladonna. At this time, the company has not agreed to conduct a recall. The FDA recommends that consumers stop using these products marketed by Hyland's immediately and dispose of any in their possession. In November 2016, Raritan Pharmaceuticals (East Brunswick, New Jersey) recalled three belladonna-containing homeopathic products, two of which were marketed by CVS."

RAPEX - RAPID ALERT SYSTEM FOR DANGEROUS NON-FOOD PRODUCTS - SISTEMA EUROPEO DI ALLERTA RAPIDA PER I PRODOTTI DI CONSUMO PERICOLOSI

The Rapid Alert System for non-food dangerous products facilitates the rapid exchange of information between national authorities of 31 countries and the European Commission on dangerous products found on the market.


The Commission publishes a weekly overview of the alerts on products reported by the national authorities. They include information on the dangerous products found, the risks identified and the measures taken in the notifying country in order to prevent or restrict their marketing or use. Measures can be ordered by national authorities ("compulsory measures") or be taken directly by producers and distributors ("voluntary measures"). Each alert also includes information on the countries where the same product was found and further measures were taken.
Updated to / Aggiornamento al 
10/02/2017
Rapid Alert System – Weekly Notification reports

venerdì 10 febbraio 2017

GAZZETTA SUMMER CAMP 2017 - CAMP SCRITTURA E TEATRO


Dal 21 al 27 giugno 2017 al Gazzetta Summer Camp di Canazei la scrittrice Annalisa Strada, l’attore Paolo Zambon e l’illustratore Fausto Bianchi insegneranno a bambini e ragazzi a scrivere e mettere in scena una storia.

Canazei (Val di Fassa), 21-27 giugno 2017- Sports Promotion promuove l’arte del teatro, dell’illustrazione e della scrittura ai giovani che parteciperanno al Gazzetta Summer Camp.

Incoraggiati a scrivere una storia da Annalisa Strada, scrittrice, insegnante, consulente editoriale; a rappresentarla insieme all’attore Paolo Zambon, attore, regista, insegnante di teatro per bambini e ragazzi, autore del format contro il bullismo “Educare al rispetto come antidoto alla violenza”; a illustrarla con l’aiuto di Fausto Bianchi illustratore, pittore e insegnante di disegno i ragazzi che parteciperanno al Camp Scrittura e Teatro vivranno una settimana magica.

Una proposta formativa unica nel suo genere che unisce parole, immagini, fantasia, risate e sport per scoprire l’affascinante mondo della scrittura e del teatro.
Responsabile del progetto è Laura Orsolini, scrittrice per ragazzi e adulti e consulente editoriale.

Al termine del corso verrà rilasciato un attestato di partecipazione valido come credito formativo.

Dal 1985 la Gazzetta dello Sport, in collaborazione con Sports Promotion, organizza i Gazzetta Summer Camp per bambini e ragazzi dai sei ai diciannove anni. I camp uniscono sport e divertimento: oltre venticinque discipline sportive diverse, tornei, giochi, passeggiate, magia e balli animeranno le giornate riempiendo i ricordi dei partecipanti di un caleidoscopio di immagini indimenticabili. Da quest’anno il camp avrà una marcia in più: i ragazzi che sognano di scrivere un libro e che amano il teatro avranno la fortuna di incontrare esperti professionisti per creare e mettere in scena una storia.

Il tutto come sempre nel meraviglioso scenario delle Dolomiti, patrimonio dell’Unesco.


Informazioni e richieste di interviste
Laura Orsolini
laura.orsolini@live.it

tel 345 8987827




giovedì 9 febbraio 2017

VIRTUAL REALITY HELPS KIDS ESCAPE FROM PAIN

From
Web site


The idea came from video game developer Simon Robertson, who also happened to be a volunteer at the University of California San Francisco Benioff Children’s Hospital in Oakland.

Decreasing the Pain Felt
Robertson said he had read about pioneering research led by Hunter Hoffman at the University of Washington in 2000, showing that VR helped decrease the pain felt by adolescent burn patients as they had their wounds dressed.
“I remember reading that and thinking, ‘Oh, that is fantastic that they do that,’” said Robertson. “I just assumed they did that in every hospital now because this research is really convincing. But I was disappointed to discover that they were not doing it at my local hospital, and they were not doing it elsewhere.”
So Robertson began creating relaxing virtual environments to help distract young people from pain.